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Background: With an ever-increasing elderly population, orthopaedic surgeons are faced with treating a high
number of fragility fractures. Biomechanical tests have demonstrated the potential role of osteoporosis in the
increased risk of fracture fixation complications, yet this has not been sufficiently proven in clinical practice. Based
on this knowledge, two clinical studies were designed to investigate the influence of local bone quality on the
occurrence of complications in elderly patients with distal radius and proximal humerus fractures treated by open
reduction and internal fixation.
Methods/Design: The studies were planned using a prospective multicentre open cohort design and included
patients between 50 and 90 years of age. Distal radius and proximal humerus fractures were treated with locking
compression 2.4 mm and proximal humerus internal locking plates, respectively. Follow-up examinations were
planned for 6 weeks, 3 and 12 months as well as a telephone interview at 6 months. The primary outcome focuses
on the occurrence of at least one local bone quality related complication. Local bone quality is determined by
measuring bone mineral density and bone mineral content at the contralateral radius. Primary complications are
categorised according to predefined factors directly related to the bone/fracture or the implant/surgical technique.
Secondary outcomes include the documentation of soft tissue/wound or general/systemic complications, clinical
assessment of range of motion, and patient-rated evaluations of upper limb function and quality of life using both
objective and subjective measures.
Discussion: The prospective multicentre open cohort studies will determine the value of local bone quality as
measured by bone mineral density and content, and compare the quality of local bone of patients who
experience a complication (cases) following surgery with that of patients who do not (controls). These
measurements are novel and objective alternatives to what is currently used.
Trial registration numbers: Clinical Trials.gov NCT01144208 and NCT01143675.
Background
Osteoporosis leads to rarefaction of the intrinsic bone
structure [1]. Thinning of the cortical shell in combina-
tion with less and thinner trabeculae [2] leads to inferior
mechanical properties, e.g. lower compression force [3].
The subsequent increased incidence of low-energy
fractures is well-known [4,5]. It is also known from epi-
demiological studies that permanent, untreated osteo-
porosis significantly increases the risk for another
fracture [6] and furthermore, aggravates fracture fixa-
tion. The latter has been demonstrated in a number of
biomechanical experiments that assessed various implant
configurations (e.g. single screws, screw-plate constructs,
dynamic hip screws) at different bone locations (e.g.
proximal humerus, proximal femur or vertebra) under
different loading modes (e.g. quasi-static, limited cyclic)
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mineral density (BMD) [8] or more precisely with the
minimal contact area between implant and low density
bone [9]. Consequently, fixation strength should be
affected by osteoporosis and a higher risk for fixation
failure in the form of screw pull-out or cut-through for
example, might be expected.
Despite these biomechanical findings, very few clinical
studies have reported an association between osteoporosis
and an increased risk of fixation failure [10,11]. A recent
systematic literature review also revealed that despite
strong biomechanical evidence, an association could not
be reproduced in clinical studies [7]. Furthermore, two
reasons for the missing link were identified: 1) the lack of
appropriate local osteoporosis diagnostics, and 2) the lack
of uniform definitions for complications. The first aspect
seems logical since current osteoporosis diagnostic tools
were developed only to predict an overall fracture risk and
not the local risk of fixation failure. Eckstein et al showed
a substantial heterogeneity in BMD across different mea-
surement sites and also found that local bone strength is
best predicted by site-specific measurement [12]. Thiele et
al showed that locally measured bone morphometric para-
meters like cortical bone mass, cortical thickness and bone
density can explain more than 80% of the pull-out
strength at the proximal femur [13]. Seebeck et al found
an increase of up to 93 and 98% considering the adjacent
cortical thickness and cancellous bone density measure-
ments along single screws, respectively [8]. All these find-
ings demonstrate the need for appropriate local bone
density/morphometry assessment to evaluate a possible
association with fixation failure.
Reports on complications occurring after surgical frac-
ture treatment are rare and usually accompanied with
inconsistency. This is the main reason for the absence
of a universal classification system defining complica-
tions and thereby, a lack of clinical correlation between
osteoporosis and the risk of fracture fixation failure. A
recent systematic literature review of orthopaedic rando-
mised controlled trials revealed that awareness and qual-
ity of reporting are low among orthopaedic surgeons
[14]. Some authors report all complications without
stratification for the possible relation to the intervention,
whereas others either do not observe complications or
simply do not report them. Systematic complication
definitions including a characterisation of their possible
relation to the tested interventions are a major prerequi-
site for studies focusing on bone quality and fixation.
The focus of this article is to describe a protocol that
was designed to examine a hypothesised association
between local bone quality and the risk of fixation fail-
ure. Local bone quality is measured using an up-to-date
diagnostic tool for assessing local BMD and the risk of
fixation failure is derived from a final independent
assessment of the number of complications related to a
defined set of categorised factors, i.e. local bone, frac-
ture, implant or the surgical application. The protocol is
applied in two specific clinical studies focusing on com-
mon fracture locations often associated with osteoporo-
sis, the distal radius and proximal humerus.
Methods/design
Study design
Both studies are designed as prospective, multicentre
open cohort studies with a nested case-control design.
Open cohorts do not select subjects according to the
type of exposure variable but enrol all members of the
population and determine subsequent exposure status.
In this case, exposure (i.e. local BMD level) has already
occurred, but is not a criterion for subject enrolment.
The major advantage of this type of approach as com-
pared to a classical case control design is that in addi-
tion to comparing the BMD in cases and controls, we
can also obtain an estimate of the risk of experiencing a
complication in the general population.
The studies will be conducted at several participating
clinics from Austria, Germany, Switzerland, Italy, China,
Singapore and the US; recruitment will take place at 11
hospitals for the distal radius and 9 for the proximal
humerus studies (Table 1).
The clinical investigation plan was approved by the
local ethics committees of all participating centers.
Informed consent is obtained from each patient before
data collection.
Identification and recruitment of study participants
Patients between and including 50 and 90 years old are
eligible for a study. The main inclusion criterion is a
radiologically confirmed closed distal radius or proximal
humerus fracture not older than 7 or 10 days, respec-
tively (Table 2 and 3). For proximal humerus cases, only
those patients with normal age-dependent function
prior to operation, a monotrauma, and fracture displace-
ment with a segment displacement of 0.5 cm or angula-
tion > 45° [15] except dislocated fractures of the greater
and lesser tuberosity will be recruited (Table 3).
Patients with open fractures, a concomitant contralat-
eral fracture at the same location, or a previous fracture
on either side after the age of 25 years are excluded.
Furthermore, patients receiving regular systemic therapy
with corticosteroids due to chronic disease are excluded.
For the proximal humerus study, patients are excluded
as well when they had cuff arthropathy of the contralat-
eral side or associated nerve or vessel injuries (Table 3).
Treatment
At the distal radius, a volar 2.4 mm locking compression
plate (LCP) is used for stable internal fixation with a
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mal humerus interlocking (PHILOS) plate is used for
primary treatment of the upper limb fracture group.
Both implants (Synthes GmbH, Oberdorf, Switzerland)
are applied using standard recommended surgical proce-
dures [17,18].
Primary outcome measure
The primary aim of both studies is to evaluate if
patients who experience bone/fracture or implant/sur-
gery complications following surgical treatment with
open reduction and a fixation plate (cases) have poorer
bone quality (determined by local BMD) compared to
control patients who do not experience a complication;
hence, whether there is an association between poor
bone mineral density and the risk of complication.
Therefore, the main outcome involves documentation of
the occurrence of at least one local bone quality related
complication during 12 months of follow-up. The classi-
fication of complications complies with the previously
defined system of AO Clinical Investigation and Docu-
mentation [19]. The qualifying events include those
directly involving either the local bone and fracture or
the implant and its surgical application. A detailed defi-
nition of these clinical and/or radiologically detectable
events for the distal radius and proximal humerus are
listed in Table 4 and 5, respectively.
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Table 2 Eligibility criteria for the distal radius fracture
group
Inclusion criteria (distal radius)
￿ Radiologically confirmed closed fracture (≤ 7 days) of the distal
radius
￿ Primary fracture treatment with a volar LCP 2.4 mm
￿ Age > 50 and < 90 years
￿ Willing and able to give written informed consent to participate
in the study
￿ Willing and able to participate in the study follow-ups according
to the study protocol
￿ Willing and able to comply with the postoperative management
program
￿ Able to understand and read country national language at an
elementary level
Exclusion criteria (distal radius)
￿ Ulna fracture (except an associated fracture of the ulnar styloid
process)*
￿ Open distal radius fracture
￿ Concomitant contralateral radius fracture
￿ Previous distal radius fracture on either side after the age of 25
￿ Time to operation > 7 days
￿ Polytrauma
￿ Regular systemic therapy with corticosteroids due to chronic
disease
￿ Legal incompetence
￿ Patient received radio- or chemotherapy prior to, during or within
the last year
￿ Currently diagnosed with active cancer
￿ Recent history of substance abuse (i.e. recreational drugs, alcohol)
￿ Prisoner
￿ Currently involved in a pharmaceutical clinical study**
￿ Has a disease process that would preclude accurate evaluation
(e.g. neuromuscular or rheumatic disease, significant psychiatric or
metabolic disorders)
* a) simple fractures of the ulna neck, b) multi-fragmentary fractures of the
ulna neck, c) fractures of the ulna head and d) fractures of the ulna proximal
to the neck are excluded, while radio-ulna dislocation (fracture of the styloid
process) may be included.
** Simultaneous participation in another orthopaedic/surgical study with the
same or another fracture will be approved by the principal clinical investigator
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alignment measurements and complication events by an
independent radiologist. A final classification of all com-
plications will be performed after the end of the 12-
month follow-up period by an independent study review
board using anonymised data and radiographs.
Secondary outcome measures
Documentation of additional complications
The occurrence of any complication other than specific
bone/fracture and implant/surgery events during the 12-
month follow-up period will also be assessed for both
studies. “Any” complication comprises soft tissue/wound
and systemic/general complications.
Superficial and deep wound infections, nerve irritation
or injury, and local pain are considered as “soft tissue/
wound” complications. Reflex sympathetic dystrophy,
carpal tunnel syndrome, tendon irritation or rupture,
ganglion, and neurological symptoms (e.g. dysesthesia)
are additionally included under the definition of a soft
tissue complication specifical l yo c c u r r i n ga tt h ed i s t a l
radius. For the proximal humerus, additional soft tissue
complications include impingement, loss of range of
motion, stiffness and rotator cuff lesions.
Systemic/general complications comprise infections
localised at any site other than the fractured region, sep-
sis, thrombosis, embolism, and death.
Determination of bone mineral density (BMD)
The standard diagnostic method for classifying osteo-
porosis is the measurement of BMD at specific body
sites, namely the hip, vertebra or radius. The most com-
monly used tools for BMD measurement are dual
energy X-ray absorptiometry (DXA), quantitative com-
puted tomography (QCT), and quantitative ultrasound
[20,21].
Despite the well-known problem of comparing mea-
surement devices, target regions of interest (ROI), and
reference measurements of different populations, the
World Health Organization defines DXA as the method
most highly developed technically and most thoroughly
validated biologically. It is regarded as the ‘gold stan-
dard’ with which the performance characteristics of less
well-established techniques can be compared [22].
Therefore, DXA will be used for the nominated studies.
Although BMD is most frequently determined at the
lumbar spine, total hip and proximal femur, a peripheral
DXA method focused at the distal radius will be used.
This technique has high precision accompanied by low
radiation exposure levels [21]. Sievanen et al evaluated
the in vivo day-to-day precision of DXA for seven ana-
tomic sites in the upper left and right extremities of ten
subjects. The determined precision values of BMD for
the proximal humerus and distal radius were 0.8% and
0.7%, respectively [23].
For both studies, local bone status will be assessed by
determining the BMD of the contralateral radius. Abso-
lute values will be documented as well as the T-score
according to the DXA manufacturer’s reference collec-
tive, e.g. -1.5 standard deviations (STD). Comparisons of
BMD measurements obtained from the left and right
humeri revealed higher correlations between the distal
(r = 0.95) and proximal humerus (r = 0.86) of both
arms when compared to the proximal and distal
humerus (r = 0.63) of the same arm [24]. These data
suggest that the contralateral side is an appropriate esti-
mate of the bone quality of a fractured side.
Table 3 Eligibility criteria for the proximal humerus
fracture group
Inclusion criteria (proximal humerus)
￿ Radiologically confirmed closed fracture (≤ 10 days) of the
proximal humerus
￿ All dislocated (according to modified Neer*) proximal humerus
fractures except dislocated fractures of the greater and lesser
tuberosity
￿ Primary fracture treatment with a PHILOS plate
￿ Age ≥ 50 and ≤ 90 years
￿ Normal (pre-trauma) function of both shoulders according to age
￿ Monotrauma
￿ Willing and able to give written informed consent to participate
in the study
￿ Willing and able to participate in the study follow-ups according
to the study protocol
￿ Willing and able to comply with the postoperative management
program
￿ Able to understand and read country national language at an
elementary level
Exclusion criteria (proximal humerus)
￿ Open proximal humerus fracture
￿ Concomitant contralateral proximal humerus fracture
￿ Previous proximal humerus fracture on either side after the age of
25
￿ Time to operation > 10 days
￿ Polytrauma
￿ Cuff arthropathy of the contralateral proximal humerus
￿ Associated nerve or vessel injury
￿ Regular systemic therapy with corticosteroids due to chronic
disease
￿ Legal incompetence
￿ Patient received radio- or chemotherapy prior to, during or within
the last year
￿ Currently diagnosed with active cancer
￿ Recent history of substance abuse (i.e. recreational drugs, alcohol)
￿ Prisoner
￿ Currently involved in a pharmaceutical clinical study**
￿ Has a disease process that would preclude accurate evaluation
(e.g. neuromuscular or rheumatic disease, significant psychiatric or
metabolic disorders)
* Segment displacement > 0.5 cm or angulated > 45° [15].
** Simultaneous participation in another orthopaedic/surgical study with the
same or another fracture will be approved by the principal clinical investigator
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Regular physical exam of the wrist or shoulder involves
the determination of range of motion [25].
Patient self-evaluation of their upper limb function
and health related quality of life status will be assessed
using the Disabilities of the Arm, Shoulder and Hand
(DASH) [26] and EuroQol 5 [27] questionnaires, respec-
tively. The DASH is a 30-item survey which will be
used in its original or translated validated versions, and
allows the patient to rate and describe their upper limb
disability during the last week as well as monitor
changes in symptoms and function over time. For the
health related quality of life assessment, an adapted
version of the EuroQoL 5 will be used. The original 20
cm visual analogue scale with endpoints labelled “worst
imaginable health state” and “best imaginable health
state” anchored at 0 and 100 respectively, has been
changed to an 11-point visual numeric scale ranging
from 0 to 10. This alternate response format has already
been used in clinical studies and is more suitable for the
telephone interview. Because the baseline questionnaire
will be filled out by the patient after the accident and
operation, the question “please indicate how you feel
today” will be modified to “please indicate how you felt
before the operation” in order to obtain a pre-injury
baseline value.
Table 4 Detailed list of categorised definitions for bone/fracture and implant/surgery complications located at the
distal radius
Bone/fracture
(Secondary) Loss of reduction
= secondary fragment dislocation
= redisplacement
= loss of radial/ulnar length
= dorsal angle change
= dorsal or palmar shortening
Any change in intra-/extraarticular angles, radial/ulnar length or secondary fragment dislocation
compared to the immediate postoperative measurements
Malunion Healed fracture in deformity (e.g. varus/valgus, rotational malunion) as a consequence of loss of
reduction
Malunion
= residual extraarticular deformity
= residual articular gap/step-off
Inadequate/insufficient anatomical reduction as a consequence of significant change of the
postoperative position. Bone unites in abnormal position and/or alignment
Fracture impaction Articular impaction of ≥ 1m m
Delayed healing Insufficient signs of healing (> 3 months)
Nonunion Indiscernible signs of healing (> 6 months)
Refracture
= secondary fracture
Fracture occurs at the same radial site with a load level otherwise tolerated by normal bone after the
bone has solidly bridged
Functional deficit As assessed with the functional scores of DASH, PRWE, ROM and grip strength
Implant/surgery
Primary malpositioning of plate Failure to fix each fragment and/or failure to implant plate according to technical guide [17]
(including anatomical reduction and plate positioning) during operation
Primary malpositioning of screw Screws placed into the radiocarpal or radioulnar joint as seen on oblique X-rays or incorrect screw size
chosen during operation
Secondary screw perforation
= secondary screw loosening
= screw back-out
Screws displaced into the radiocarpal or radioulnar joint as seen on oblique X-rays or incorrect screw
size chosen (no initial perforation)
Implant (plate and screw) loosening Multiple proximal or distal screw loosening leading to firstly, relative movement between one main
fragment and the plate and secondly, pull-out of the implant
Plate/screw failure/breakage Plate/screw breakage
Radiolucency around screw Appearance of screw on X-ray without screw loosening
DASH = Disabilities of the Arm, Shoulder and Hand questionnaire PRWE = Patient-Rated Wrist Evaluation questionnaire ROM = Range Of Motion
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distal radius
Grip strength will be evaluated using a Jamar dynam-
ometer (Sammons Preston Roylan, Bolingbrook IL,
USA). The average value of three successive measure-
ments will be calculated as a percentage of the contral-
ateral, healthy side [28]. An impairment of muscle
power is defined as a clearly lower average value for the
injured leading hand compared to the opposite hand. If
the injury involves the non-leading hand, the average
value must be 50% lower than that for the opposite
hand [29].
The Patient-Rated Wrist Evaluation questionnaire
(PRWE) is a 15-item survey which allows patients to
self-assess their levels of pain and disability in activities
of daily living. It will be used as published [30] or in a
translated validated version according to the guidelines
of Beaton et al [31].
I nas u b s e to fp a t i e n t s ,t h eb o n ev o l u m e / t r a b e c u l a r
volume (BV/TV) ratio will be measured using high
Table 5 Detailed list of categorised definitions for bone/fracture and implant/surgery complications located at the
proximal humerus
Bone/fracture
(Secondary) Loss of reduction
= secondary fragment displacement
= redisplacement
Significant change of head position against shaft or fragment dislocation compared to the
immediate postoperative position
= secondary dislocation of greater tuberosity Relative change of greater tuberosity compared to the immediate postoperative position
Malunion Fracture healed with deformity and bone unites in abnormal position and/or alignment (e.g. varus/
valgus, rotational malunion)
1. as a consequence of loss of reduction
2. as a consequence of inadequate/insufficient anatomical reduction as observed on postoperative
X-rays.
Delayed healing Insufficient signs of bridging/continuous fracture line still visible up to 6 months
Nonunion Indiscernible signs of bridging/continuous fracture line still visible after 6 months
Head impaction
= secondary fracture impaction
Secondary impaction/sintering of the head fragment with consecutive intraarticular screw
penetration due to mechanical failure (not due to avascular collapse of the head fragment)
compared to immediate postoperative position
Head necrosis In situ death of bone within the humeral head due to disruption of blood supply, leading to
partial or complete collapse of the head
Refracture
= secondary fracture at the same site
After fracture is healed: refracture occurs at the same humeral site with a load level otherwise
tolerated by normal bone after the bone has solidly bridged
Functional deficit As assessed with the functional scores of DASH, SPADI, ROM and Constant-Murley
Implant/surgery
Primary malpositioning of plate Failure to fix each fragment and/or failure to implant plate according to technical guide [18]
(including anatomical reduction and plate positioning i.e. at least 8 mm distal to the upper end of
the greater tubercle) during operation
Primary malpositioning of screw Screw perforation into glenohumeral joint during operation
Secondary screw loosening: back-out Relative change outwards of screw position in relation to postoperative position
Secondary screw loosening: perforation Perforation of one screw through the cortex of the head (no initial perforation)
Implant loosening
= Proximal screw and plate pull out
= Distal screw and plate pull out
Multiple proximal or distal screw loosening leading to firstly, relative movement between one
main fragment and the plate and secondly, pull-out of the implant
Implant failure/breakage Plate/screw breakage
DASH = Disabilities of the Arm, Shoulder and Hand questionnaire SPADI = Shoulder Pain And Disability Index ROM = Range Of Motion
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(Xtreme CT) (Scanco Medical AG, Brüttisellen, Switzer-
land) and compared with DXA measurements.
For the measurement of distal radius BMD, the
XTreme CT will be calibrated with the aid of a refer-
ence phantom [European Forearm Phantom (EFP-02-45;
QRM, Moehrendorf, Germany)] consisting of a series of
various hydroxyapatite densities.
Specific secondary outcome assessments for the proximal
humerus
The Constant-Murley score is a 100-point functional
shoulder assessment tool in which higher scores reflect
increased function. It combines four separate subscales
focusing on subjective pain, function, objective clinician
assessment of range of motion and strength. The score
will be used as originally published [32,33].
The Shoulder Pain And Disability Index (SPADI) is a
self-administered questionnaire that assesses the severity
of pain and the degree of difficulty with various activ-
ities of daily living that require upper extremity use. It
will be used as published or in its validated version [34].
As no Chinese (Cantonese) validated version of the
SPADI exists, formal translation according to established
guidelines [31,35,36] has been performed. The Chinese
version has been approved by the developer and will be
pretested in the present study in Hong Kong.
A CT based method for the measurement of BMD at
the proximal humerus will be validated, and subse-
quently used to preoperatively determine BMD for the
contralateral limb [37]. Briefly, simultaneous CT ima-
ging of the contralateral proximal humerus with a
European Forearm Phantom (EFP-02-45; QRM, Moeh-
rendorf, Germany) is performed; the phantom is placed
on the midthorax of the patient. After acquisition, the
measured CT units (Hounsfield Units [HU]) of the user-
defined ROI can then be quantified from the EFP-based
calibration curve, resulting in definitive BMD values.
This CT assessment of proximal humerus BMD will
then be compared to the DXA measurements used to
quantify BMD of the distal radius.
A summary of all outcome measures assessed during
each study is presented in Figure 1.
Timing of outcome assessments
For both studies, patients will be followed from the day
of initial treatment to one year thereafter. The follow-up
includes initial hospitalisation (baseline) and follow-up
visits at 6 weeks, 3 months and 12 months following
surgery. At these follow-ups all outcomes except radi-
ological data will be measured in the hospitals. Any
unplanned follow-up visits resulting from the occur-
rence of a complication during the 12-month period will
also be documented. Additional telephone interviews
will take place at the 6-month postoperative period to
obtain the patient self-rating PRWE, SPADI, and Euro-
Qol5 questionnaire evaluations.
Safety monitoring
Due to the investigational nature of the study to evalu-
ate the association of local BMD with the occurrence of
specific types of treatment complications, the entire
reporting process of complications/adverse events (AE)
is adapted such that the investigators are obligated to
report all types of events, independent of being classified
as a complication or an AE.
A complication is defined as any occurrence or devia-
tion from the normal treatment or outcome, regardless
of whether it has any relationship with the treatment or
product under investigation.
All complications occurring at any time during the
patient’s postoperative follow-up period will be reported
by the subject or observed by the investigator and docu-
mented in a separate complication form, whether or not
the investigator concludes the event to be related to the
treatment. The form will include the following informa-
tion:
▪ type and date of event
▪ study name and the patient identification and
treatment number
▪ investigator name and phone number
▪ name of the suspect medical product and the day
of implantation
▪ a short description of the complication
▪ event seriousness and relation to study
participation
▪ most likely causative factor
▪ event treatment
▪ event outcome and the relation (if any) of the
event to the treatment procedure
Sample size and statistical analysis
The primary objective of both studies is to assess BMD
as a risk factor for the development of treatment com-
plications. This objective will be analysed based on a
nested case-control design. Using this statistical
approach, the outcome variable is the occurrence of any
complication and the exposure variable is the BMD
measurement at the contralateral side. Cases include
subjects reported with any bone and fracture related
complication during the study duration of 12 months.
Controls are subjects without any recorded complica-
tion. Thus, the main conceptual approach in this analy-
sis is the difference in population BMD means between
the cases and controls.
A two-way superiority hypothesis that the BMD is
lower in cases compared to controls will be tested. The
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which states that the BMD is equal in cases and con-
trols, i.e. H0: μcontrols = μcases or H0: μcontrols -
μc a s e s=0 ,w h e r ec o n t r o l sa n dc a s e sa r et h em e a n so f
the two independent normal distributions. The alterna-
tive hypothesis is that BMD is different between the
cases and the controls, i.e. H1: μcontrols ≠ μcases or
H1: μcontrols - μcases ≠ 0. Rejection of the null hypoth-
esis leads to the acceptance of the alternative hypothesis.
The expected direction is that BMD is lower among the
cases, which suggests the association between low BMD
and the occurrence of complications. The expected ratio
of cases versus controls is 15:85 for distal radius frac-
tures and 30:70 for the proximal humerus. A standard
d e v i a t i o no f0 . 0 5g / c m
2 for radius BMD measurements
has been estimated [38]. With an expected BMD of 0.4
g/cm
2 at the radius and 200 subjects, the distal radius
study has 85% power to detect a difference of -0.03 g/
cm
2 in BMD at the wrist between the cases and the
controls (two-way test). This corresponds to a Cohen
Figure 1 Flow chart of the study protocol.
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Page 8 of 10effect size of 0.6, which indicates a medium clinical dif-
ference. With a power of 85%, a significance level of
0.05 (two-sided), an additional 10% in the number of
subjects to compensate for any loss of power due to an
adjustment for imbalance between the groups, and an
estimated 10% loss to follow-up at the 1-year clinical
examination, the distal radius and proximal humerus
studies require 244 and 148 patients, respectively. Our
sample size estimates are based on the following series
of assumptions: 1) the proportion of cases in the patient
population (i.e. % subjects with any complication); 2)
the standard deviation of BMD at distal radius; and 3)
t h ed i f f e r e n c eo fμcontrols - μcases. Sample size estimates
were performed using the Study East Version 4.0.1
(Cytel Statistical Software, Cambridge MA, USA).
Discussion
Although an association between local bone quality and
implant anchorage has been proven in various in vitro
settings, clinical evidence is still lacking [7]. Case reports
as well as clinical experience suggest that fractures in
osteoporotic patients are at higher risk of implant com-
plication. Quantification oft h ep r o b l e mi sr e q u i r e di n
order to a) determine the size of the problem, b) pro-
vide numbers and characteristics for implant develop-
ment, c) establish a basis for treatment decision-making,
and d) support teaching in the field of geriatric fracture
care. The proof of the hypothesised association is only
possible in a controlled setting. Therefore, our study
approach focuses on two major osteoporosis related
indications. Distal radius fractures are regarded as senti-
nel fractures. Previous studies show high correlations
between the degree of osteoporosis and radiological
healing criteria [39,40], but surgical treatment with
locked plates may have a positive impact on this correla-
tion. For proximal humerus fractures, the use of locked
plates does not seem to prevent all complications; rates
of up to 40% are reported in the literature [41,42]. In
this context, it is interesting to evaluate whether local
bone quality is a significant contributing factor.
Although the study goals and methodology are novel,
a few assumptions need to be made. Since local bone
quality cannot be measured directly at the fracture site,
remote sites have to be evaluated. Previous work has
shown that the contralateral site serves as a better sur-
rogate than ipsilateral locations in other areas [24]. Yet
conditions such as post-stroke hemiparesis have an
influence on these elements. Therefore, in the case of a
proximal humerus fracture, BMD will be measured at
the ipsilateral distal radius as well as at the contralateral
proximal humerus. In the case of a distal radius fracture,
only the contralateral side can be utilised to estimate
BMD at the fracture site.
The latest concept of complication assessment is uti-
lised for this study [19]. The main feature is that it dis-
tinguishes between local and general complications, with
the former divided into further subcategories of bone/
fracture, implant/surgery, and soft tissue associated
complications. This should enable the investigator to
establish causality. Overlapping between the categories
may influence the assessment. The new feature of cen-
tralised radiograph and complication assessment will
greatly help to improve data quality and may minimise
investigator bias in the assessment of cases and controls.
Despite significant efforts to unify surgical care in
both treatment arms, many confounding variables may
influence the hypothesised association. Differences in
the surgical approach, surgical skills, hospital infrastruc-
ture and postoperative rehabilitation may contribute to
variability in the final result, thus influencing and possi-
bly masking a bone related effect. Nevertheless, the
study protocol adopts a real-world approach and there-
fore, represents current clinical practice rather than a
theoretical framework.
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